Incline Therapeutics to Present at the Leerink Swann and Company 2012 Global Healthcare Conference

Published: Feb 13, 2012

REDWOOD CITY, Calif., Feb. 13, 2012 /PRNewswire/ -- Incline Therapeutics, Inc., a hospital-focused specialty pharmaceutical company, announced today that Alan Levy, PhD, Chief Executive Officer, and David Socks, President and Chief Operating Officer, will present at the Leerink Swann Global Healthcare Conference on Wednesday, February 15, 2012 at 11:00a.m. Eastern Time at the Waldorf-Astoria Hotel in New York City.

About Incline Therapeutics, Inc.

Incline Therapeutics is a hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system), a compact, disposable, needleless patient-controlled system for the short-term management of acute postoperative pain in adult patients requiring opioid analgesia during hospitalization. IONSYS has completed Phase III development and was previously approved in the United States and Europe. Prior to marketing IONSYS, Incline must seek approval of a supplement New Drug Application (sNDA) in the United States and a Marketing Authorization Application (MAA) in Europe. Incline is financed by leading life science venture capital firms and led by a management team with significant pharmaceutical and medical device industry experience. The company is based in Redwood City, California.

Incline and IONSYS are trademarks of Incline Therapeutics, Inc.

SOURCE Incline Therapeutics, Inc.

Back to news